Equities

Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic The

Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic The

Actions
  • Price (EUR)1.17
  • Today's Change0.022 / 1.92%
  • Shares traded0.00
  • 1 Year change14.51%
  • Beta--
Data delayed at least 15 minutes, as of Feb 26 2020.
More ▼

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic The had revenues fall -13.05% from 114.16m to 99.25m, though the company grew net income 4.37% from 12.50m to 13.04m.
Gross margin23.32%
Net profit margin5.59%
Operating margin19.02%
Return on assets1.87%
Return on equity4.78%
Return on investment2.36%
More ▼

Cash flow in EURView more

In 2018, Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic The increased its cash reserves by 57.28%, or 9.15m. The company earned 17.14m from its operations for a Cash Flow Margin of 17.26%. In addition the company generated 15.15m cash from investing, though they paid out 23.14m more in financing than they received.
Cash flow per share0.105
Price/Cash flow per share13.82
Book value per share1.20
Tangible book value per share1.20
More ▼

Balance sheet in EURView more

Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic The has a Debt to Total Capital ratio of 40.76%, a lower figure than the previous year's 61.77%.
Current ratio1.34
Quick ratio1.30
Total debt/total equity0.6869
Total debt/total capital0.4076
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.